AU2001254710A1 - Non-steroidal, tetracyclic compounds for estrogen-related treatments - Google Patents

Non-steroidal, tetracyclic compounds for estrogen-related treatments

Info

Publication number
AU2001254710A1
AU2001254710A1 AU2001254710A AU5471001A AU2001254710A1 AU 2001254710 A1 AU2001254710 A1 AU 2001254710A1 AU 2001254710 A AU2001254710 A AU 2001254710A AU 5471001 A AU5471001 A AU 5471001A AU 2001254710 A1 AU2001254710 A1 AU 2001254710A1
Authority
AU
Australia
Prior art keywords
estrogen
alkenyl
alkyl
compounds
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001254710A
Other languages
English (en)
Inventor
Eduard De Zwart
Hubert Loozen
Jordi Mestres
Gerrit Veeneman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2001254710A1 publication Critical patent/AU2001254710A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/21—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
AU2001254710A 2000-03-27 2001-03-21 Non-steroidal, tetracyclic compounds for estrogen-related treatments Abandoned AU2001254710A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00201105 2000-03-27
EP00201105 2000-03-27
EP00201103 2000-03-27
EP00201103 2000-03-27
PCT/EP2001/003187 WO2001072713A1 (en) 2000-03-27 2001-03-21 Non-steroidal, tetracyclic compounds for estrogen-related treatments

Publications (1)

Publication Number Publication Date
AU2001254710A1 true AU2001254710A1 (en) 2001-10-08

Family

ID=26072045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001254710A Abandoned AU2001254710A1 (en) 2000-03-27 2001-03-21 Non-steroidal, tetracyclic compounds for estrogen-related treatments

Country Status (9)

Country Link
US (1) US6686371B2 (es)
EP (1) EP1272471B1 (es)
JP (2) JP2003528858A (es)
AT (1) ATE374752T1 (es)
AU (1) AU2001254710A1 (es)
DE (1) DE60130748T2 (es)
ES (1) ES2293986T3 (es)
PE (1) PE20011131A1 (es)
WO (1) WO2001072713A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
CZ2003514A3 (cs) * 2000-08-23 2003-10-15 Akzo Nobel N. V. Fluorenové deriváty a jejich analogy
WO2003015761A1 (en) * 2001-08-13 2003-02-27 Merck & Co., Inc. Selective estrogen receptor modulators
EA007382B1 (ru) 2001-11-19 2006-10-27 Эли Лилли Энд Компани Замещенные бензопираны в качестве селективных агонистов бета-рецептора эстрогена
TW200408385A (en) * 2001-12-21 2004-06-01 Akzo Nobel Nv Tetrahydrobenzfluorene derivatives
TW200304371A (en) * 2002-02-22 2003-10-01 Akzo Nobel Nv Substituted 10-ary1-11H-benzo [b] fluorenes and 7-ary1-5, 6-dihydro-benz [a] anthracenes for selective effects on estrogen receptors
US6849348B2 (en) * 2002-12-31 2005-02-01 Eastman Kodak Company Complex fluorene-containing compounds
ATE457308T1 (de) 2003-04-21 2010-02-15 Lilly Co Eli Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
CA2518819A1 (en) 2003-04-21 2004-11-04 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor-beta agonists
JP2008512458A (ja) 2004-09-07 2008-04-24 ワイス ６Ｈ−［１］ベンゾピラノ［４，３−ｂ］キノリン及びエストロゲン様物質としてのそれらの使用
WO2016031415A1 (ja) * 2014-08-27 2016-03-03 富士フイルム株式会社 組成物、膜、光学機器、化合物
CN104327088A (zh) * 2014-09-24 2015-02-04 大连理工大学 一种7-氯-6H-苯并吡喃[4,3-b]喹啉及其衍生物的制备方法
CN104262357B (zh) * 2014-09-24 2017-05-03 大连理工大学 一种7‑氯‑6H‑苯并噻喃[4,3‑b]喹啉及其衍生物的制备方法
CN104292243A (zh) * 2014-09-24 2015-01-21 大连理工大学 一种苯并噻喃[4,3-b]喹啉及其衍生物的制备方法
CN108947947A (zh) * 2017-05-17 2018-12-07 北京新领先医药科技发展有限公司 一种沃拉帕沙中间体的制备方法
CN115785148A (zh) * 2022-11-17 2023-03-14 江西科技师范大学 一种硫代膦（磷）酸酯取代苯并芴化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
US5147880A (en) * 1991-07-22 1992-09-15 Eli Lilly And Company Benzo[a]fluorene compounds
US5688810A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
JP3141148B2 (ja) 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
NZ334954A (en) * 1996-09-23 2000-08-25 Univ Rutgers Substituted heterocycles as anti-tumor agents
MXPA05003446A (es) * 2002-10-01 2005-07-05 Dainippon Pharmaceutical Co Compuestos espiro, composiciones medicinales que contienen los mismos, e intermediarios de los compuestos.

Also Published As

Publication number Publication date
WO2001072713A1 (en) 2001-10-04
EP1272471B1 (en) 2007-10-03
EP1272471A1 (en) 2003-01-08
ES2293986T3 (es) 2008-04-01
JP2003528858A (ja) 2003-09-30
US6686371B2 (en) 2004-02-03
JP2009292824A (ja) 2009-12-17
DE60130748D1 (de) 2007-11-15
US20030144313A1 (en) 2003-07-31
ATE374752T1 (de) 2007-10-15
DE60130748T2 (de) 2008-07-17
PE20011131A1 (es) 2001-11-12

Similar Documents

Publication Publication Date Title
AU2001254710A1 (en) Non-steroidal, tetracyclic compounds for estrogen-related treatments
BR0009814A (pt) Processo para tratar de uma doença associada com o receptor-beta estrogênico
PE134199A1 (es) Inhibicion de la oxidacion de lipoproteinas
HK1056181A1 (zh) 作為抗炎劑的17β-硫代羧酸酯17α-芳基羰氧基氧雄甾烷衍生物
ATE192649T1 (de) Stereochemische wortmanninderivate
BR0113053A (pt) Uso de benzilidenoaminoguanidinas e hidroxiguanidinas como ligantes para os receptores de melanocortina
UA83620C2 (ru) Замещенные бензоксазолы и их аналоги как эстрогенные агенты
WO2005077968A8 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
YU43002A (sh) Metod za hemoprevenciju kancera prostate
AU4246501A (en) 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity
BR0112364A (pt) Combinações de bisfosfonatos, agentes estrogênicos e opcionalmente estrogênios
BR0215058A (pt) 2-fenil benzofuranos substituìdos como agentes estrogênicos
ES2154560B1 (es) Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
DE69901250D1 (de) 7.alpha.-methyl 19-nortestosteron undecanoat mit androgenischer aktivität
ZA200300929B (en) 17.Beta.-carbothioate 17.Alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents.
PL366101A1 (en) Gel composition and trans/scrotal application of a composition for the treatment of hypogonadism
ES2164400T3 (es) Esteroides con actividad anticonceptiva y antiosteoporotica.
IL148116A0 (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ATE277913T1 (de) Bisarylderivate mit fsh rezeptor modulierender aktivität
ES2183288T3 (es) Compuestos de indeno con actividad como moduladores selectivos de receptores de estrogenos.
WO2000010543A3 (de) Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung
ATE377605T1 (de) 6-oxygenierte steroid-estrogene mit aromatischen a- und b-ringen
HK1052012A1 (en) 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity.
EP0823437A3 (en) 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators